Investor Site Visit

RNS Number : 2145T

Surgical Innovations Group PLC

02 December 2011

 

For immediate release

2 December 2011

Surgical Innovations Group plc

("SI" or "the Group")

 Investor site visit

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, will today be hosting an investor site visit at its manufacturing facility in Leeds.

No new trading or financial information will be disclosed during the visit.

-Ends-

For further enquiries:

Surgical Innovations Group plc
Doug Liversidge, Chairman
Graham Bowland, Chief Executive Officer                                                                              [phone]

Seymour Pierce Limited
Freddy Crossley/Sarah Jacobs                                                                                         Tel: [phone]

Corporate Broking
David Banks                                                                                                                       www.seymourpierce.com

The Communications Portfolio
Ariane Comstive / Caolan Mahon                                                                                 [phone] / 2029

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets. 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 140 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand	Through an established network of 45 distribution partners, Surgical Innovations branded products are sold in all major medical markets including North America, Europe, South Africa, the Middle East, South-east Asia and Australia.
OEM and IP	The Group supplies large medical device companies on an OEM basis, collecting sales fees as well as IP license and royalty fees.  Clients include Teleflex Medical, Olympus, Gyrus and CareFusion.
Industrial	SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

For more information, see www.surginno.com 

 

END

 

 

MSCEAXAFEEXFFFF